Congress:
ECR25
Poster Number:
C-25635
Type:
Poster: EPOS Radiologist (educational)
Authorblock:
R. Pavlyuk, O. Sas; Kyiv/UA
Disclosures:
Romanna Pavlyuk:
Nothing to disclose
Olena Sas:
Nothing to disclose
Keywords:
Bones, Hybrid Imaging, Oncology, CT, MR-Diffusion/Perfusion, PET-CT, Diagnostic procedure, Technology assessment, Cancer, Image verification, Outcomes
- Heindel, W., Gübitz, R., Vieth, V., Weckesser, M., Schober, O., & Schäfers, M. (2014). The diagnostic imaging of bone metastases. Deutsches Ärzteblatt International, 111(44), 741.
- Lecouvet, F. E., Larbi, A., Pasoglou, V., Omoumi, P., Tombal, B., Michoux, N., ... & Vande Berg, B. C. (2013). MRI for response assessment in metastatic bone disease. European radiology, 23, 1986-1997.
- Schraml, C., Schwenzer, N. F., Sperling, O., Aschoff, P., Lichy, M. P., Müller, M., ... & Pfannenberg, C. (2013). Staging of neuroendocrine tumours: comparison of [68Ga] DOTATOC multiphase PET/CT and whole-body MRI. Cancer imaging, 13(1), 63.
- Lecouvet, F. E., Chabot, C., Taihi, L., Kirchgesner, T., Triqueneaux, P., & Malghem, J. (2024). Present and future of whole-body MRI in metastatic disease and myeloma: How and why you will do it. Skeletal Radiology, 53(9), 1815-1831.